Concepedia

Erel Joffe

EJ

30

Publications

1.3K

Citations

20

H-Index

2009

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Tel Aviv Sourasky Medical Center

Tel Aviv University

Rabin Medical Center

The University of Texas Health Science Center at Houston

Erel Joffe is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2009–2023

30

Publications

30

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

David Sermer, Connie Lee Batlevi, M. Lia Palomba et al. · Blood Advances · 2020 · 113 citations · Full text

, , +17

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Sabela Bobillo, Erel Joffe, David Sermer et al. · Blood Cancer Journal · 2021 · 64 citations · Full text

Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era

Sabela Bobillo, Erel Joffe, Jessica A. Lavery et al. · Blood · 2020 · 63 citations · Full text

Rows per page

1–5 of 30